System and methods for automatically recognizing a control solution
View Patent ↗Methods and devices for automatically distinguishing between a control solution and an actual patient/user sample in a biosensor are provided. The solution is introduced into an electrochemical cell having a working and counter electrode. Electric pulses are applied to the cell and resultant signals are measured. Based on a comparison of the measured signals, a meter can determine whether the sample is a control solution or an actual patient/user sample.
1. A system for automatically distinguishing between a control solution having a known, predetermined concentration of an analyte and an actual patient/user sample in a biosensor comprising:
a sample reception region;
a reaction reagent system in said sample reception region comprising:
an oxidation-reduction enzyme specific for the analyte;
a first electron mediator capable of being reversibly reduced and oxidized; and
a second electron mediator, capable of being reversibly reduced and oxidized, wherein the second electron mediator has a redox potential different from that of the first mediator; and
a distinction system configured to detect the electro-chemical response signal produced by the reduction of the second electron mediator in order to identify a control solution.
2. The system of claim 1 , wherein the control solution comprises the second electron mediator.
3. The system of claim 1 , wherein the analyte is glucose.
4. The system of claim 1 , wherein the second electron mediator does not interfere with the measurement of the analyte.
5. The system of claim 1 , wherein the first electron mediator is a ruthenium containing material.
6. The system of claim 5 , wherein the ruthenium containing material comprises hexaamine (III) trichloride.
7. The system of claim 1 , wherein the second mediator is Ferrocene Dicarboxylic Acid.
8. The system of claim 1 , wherein the second mediator is Ferrocenecarboxylic Acid.
9. The system of claim 1 , wherein the second mediator is gentisic acid (2,5-dihydroxybenzoic acid).
10. The system of claim 1 , wherein the second mediator is 2,3,4-trihydroxybenzoic acid.
11. The system of claim 1 , wherein the second mediator is reduced in a potential range distinguishable from that of the first mediator.
12. The system of claim 1 , wherein the second electron mediator is reduced at a potential having a magnitude at least 0.2 volts greater or less than that used to oxidize or reduce the first electron mediator.
13. The system of claim 1 , wherein the distinction system comprises a meter configured to apply at least a first and a second electric pulse to the biosensor.
14. The system of claim 13 , wherein the distinction system is configured to measure at least a first and a second current signal generated in response to at least the first and the second applied electric pulses.
15. The system of claim 13 , wherein electric potentials of at least the first and the second applied electric pulses are of different magnitudes.
16. The system of claim 1 , wherein the distinction system is configured to measure a hematocrit level of the control solution or the actual patient/user sample.